ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 65 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q4 2017. The put-call ratio across all filers is 0.03 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $10,440,000 | -40.6% | 500,000 | -72.2% | 0.03% | -49.1% |
| Q1 2020 | $17,586,000 | +52.7% | 1,800,000 | +80.0% | 0.05% | +89.3% |
| Q4 2019 | $11,520,000 | +111.4% | 1,000,000 | 0.0% | 0.03% | +115.4% |
| Q3 2019 | $5,450,000 | -84.7% | 1,000,000 | -66.7% | 0.01% | -85.4% |
| Q2 2019 | $35,670,000 | +126.9% | 3,000,000 | 0.0% | 0.09% | +128.2% |
| Q1 2019 | $15,720,000 | +66.3% | 3,000,000 | 0.0% | 0.04% | +50.0% |
| Q4 2018 | $9,450,000 | -47.9% | 3,000,000 | 0.0% | 0.03% | -35.0% |
| Q3 2018 | $18,150,000 | -14.4% | 3,000,000 | -25.0% | 0.04% | -18.4% |
| Q2 2018 | $21,200,000 | +4.4% | 4,000,000 | +14.3% | 0.05% | +4.3% |
| Q1 2018 | $20,300,000 | +132.0% | 3,500,000 | +40.0% | 0.05% | +135.0% |
| Q4 2017 | $8,750,000 | +19.9% | 2,500,000 | +25.0% | 0.02% | +11.1% |
| Q3 2017 | $7,300,000 | +46.0% | 2,000,000 | 0.0% | 0.02% | +50.0% |
| Q2 2017 | $5,000,000 | – | 2,000,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 420,000 | $1,134,000 | 0.67% |
| EcoR1 Capital, LLC | 874,447 | $2,361,000 | 0.60% |
| VHCP Management II, LLC | 280,000 | $756,000 | 0.31% |
| 683 Capital Management, LLC | 350,000 | $945,000 | 0.15% |
| AWM Investment Company, Inc. | 400,000 | $1,080,000 | 0.10% |
| JW Asset Management, LLC | 178,654 | $482,000 | 0.10% |
| TFS CAPITAL LLC | 89,156 | $241,000 | 0.08% |
| Rhenman & Partners Asset Management AB | 154,006 | $416,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 282,630 | $763,000 | 0.04% |
| Numeric Investors LLC | 1,087,967 | $2,938,000 | 0.03% |